Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 25% ± 9% | |
astrocyte | 5 studies | 24% ± 5% | |
GABAergic neuron | 4 studies | 27% ± 5% | |
glutamatergic neuron | 4 studies | 26% ± 4% | |
oligodendrocyte precursor cell | 4 studies | 25% ± 6% | |
microglial cell | 3 studies | 21% ± 1% | |
neuron | 3 studies | 22% ± 4% | |
epithelial cell | 3 studies | 28% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 21% ± 2% | |
oligodendrocyte | 3 studies | 24% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2190.55 | 180 / 180 | 100% | 19.38 | 430 / 430 |
prostate | 100% | 1775.88 | 245 / 245 | 100% | 23.26 | 502 / 502 |
breast | 100% | 1474.76 | 459 / 459 | 100% | 37.09 | 1116 / 1118 |
lung | 100% | 1105.36 | 577 / 578 | 100% | 18.08 | 1153 / 1155 |
bladder | 100% | 1369.67 | 21 / 21 | 100% | 19.70 | 502 / 504 |
brain | 100% | 951.69 | 2633 / 2642 | 100% | 21.14 | 704 / 705 |
intestine | 100% | 1566.19 | 966 / 966 | 99% | 24.21 | 524 / 527 |
stomach | 100% | 1283.54 | 359 / 359 | 99% | 23.00 | 284 / 286 |
esophagus | 100% | 1176.74 | 1445 / 1445 | 99% | 15.21 | 181 / 183 |
pancreas | 100% | 1135.20 | 328 / 328 | 99% | 16.38 | 176 / 178 |
thymus | 100% | 1415.87 | 653 / 653 | 99% | 13.67 | 596 / 605 |
uterus | 100% | 1844.64 | 170 / 170 | 97% | 18.56 | 447 / 459 |
skin | 100% | 1230.58 | 1805 / 1809 | 97% | 15.55 | 459 / 472 |
kidney | 100% | 945.64 | 89 / 89 | 96% | 12.01 | 869 / 901 |
adrenal gland | 100% | 1492.04 | 258 / 258 | 93% | 10.75 | 215 / 230 |
liver | 100% | 749.93 | 226 / 226 | 92% | 10.27 | 374 / 406 |
adipose | 100% | 1170.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1266.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1004.33 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.11 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.12 | 1 / 1 |
heart | 97% | 611.45 | 839 / 861 | 0% | 0 | 0 / 0 |
muscle | 97% | 431.23 | 777 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 26.80 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 94% | 11.51 | 75 / 80 |
peripheral blood | 43% | 455.25 | 401 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006220 | Biological process | pyrimidine nucleotide metabolic process |
GO_0006541 | Biological process | glutamine metabolic process |
GO_0019856 | Biological process | pyrimidine nucleobase biosynthetic process |
GO_0006241 | Biological process | CTP biosynthetic process |
GO_0044210 | Biological process | 'de novo' CTP biosynthetic process |
GO_0097268 | Cellular component | cytoophidium |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0003883 | Molecular function | CTP synthase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | CTPS2 |
Protein name | CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2) CTP synthase (glutamine hydrolyzing) (EC 6.3.4.2) |
Synonyms | |
Description | FUNCTION: Catalyzes the ATP-dependent amination of UTP to CTP with either L-glutamine or ammonia as the source of nitrogen. Constitutes the rate-limiting enzyme in the synthesis of cytosine nucleotides. . |
Accessions | ENST00000359276.9 Q9NRF8 ENST00000443824.5 H0Y5S6 ENST00000455276.1 ENST00000380241.7 |